QuantLogix ← CL scorecard
📅 CL Earnings Preview
Colgate-Palmolive Company
Next report (est.)
September 16, 2026
Countdown
95 days
EPS growth YoY
-5.9%
Revenue growth YoY
+8.4%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
May 1, 2026 ±1.8% +2.2% under-priced
October 31, 2025 ±1.6% +0.7% over-priced
August 1, 2025 ±2.0% -0.4% over-priced
April 25, 2025 ±2.6% +1.3% over-priced
October 25, 2024 ±1.3% -4.1% under-priced
April 26, 2024 ±1.4% +1.9% under-priced
October 27, 2023 ±1.4% -1.8% under-priced
July 28, 2023 ±1.3% -1.9% under-priced
Across these reports, options implied an average ±1.7% move vs an actual average of 1.8% — the stock stayed inside the implied band 38% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q1 FY2026 $0.80 $5.3B $681M
Q4 FY2025 $-0.04 $5.2B $-5M
Q3 FY2025 $0.91 $5.1B $766M
Q2 FY2025 $0.91 $5.1B $773M
Analyst posture
Buy / Strong Buy
20
Hold
9
Sell
1
Stable: +0 net change 30d
Live 5-factor engine read: Buy · 66/100 Full scorecard →
Get alerted before every CL report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on CL before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Colgate-Palmolive Company (CL) reports in 95 days, with the next report estimated for September 16, 2026. Across the last 8 reports, options priced an average ±1.7% earnings move while the stock actually moved 1.8% on average — the market has been roughly fair on CL's earnings risk. Fundamentals into the print: EPS down 5.9% year-over-year, revenue up 8.4%. QuantLogix's live 5-factor engine currently reads CL as a buy at 66/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →